Filing Details

Accession Number:
0001209191-15-053983
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-16 18:56:42
Reporting Period:
2015-06-15
Filing Date:
2015-06-16
Accepted Time:
2015-06-16 18:56:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557421 Ignyta Inc. RXDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1618399 Robert Wild C/O Ignyta, Inc.
11111 Flintkote Ave.
San Diego CA 92121
Sr. Vp, Research And Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-15 1,200 $16.35 1,200 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $16.33 to $16.35. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.